Phosphoprotein Detection Using a Chip-Based Pillar Array

    公开(公告)号:US20190331561A1

    公开(公告)日:2019-10-31

    申请号:US16506826

    申请日:2019-07-09

    Abstract: Techniques for phosphoprotein detection, quantification, and purification using a chip-based pillar array are provided. In one aspect, a method for purifying a protein sample includes: introducing a mixture including the protein sample and an antibody to a nanoDLD array having a plurality of pillars separated by a gap g, wherein the antibody and proteins in the protein sample form antibody-protein complexes having a size that is greater than a size threshold of the nanoDLD array created by the gap g which permits size-based separation of the antibody-protein complexes as the mixture flows through the nanoDLD array; and collecting a purified protein sample containing the antibody-protein complexes from the nanoDLD array. A lab-on-a-chip (LOC) device including the nanoDLD array is also provided.

    Predicting Therapeutic Targets for Patients UNresponsive to a Targeted Therapeutic

    公开(公告)号:US20180046771A1

    公开(公告)日:2018-02-15

    申请号:US15236495

    申请日:2016-08-15

    CPC classification number: G16H50/20 G16B20/00 G16B20/30 Y02A90/26

    Abstract: Embodiments may provide the capability to identify genes or biological processes that may be targeted by other therapeutics in a group of individuals who are less likely to benefit from a specific targeted therapeutic. For example, a method may comprise receiving an indication of a biomarker or biological characteristic to be used to stratify patients into those who can benefit from a specified therapy or intervention versus those who have less or no benefit, computing an impact of the genomic state of at least one gene on survival or clinical progression of patients in the two groups, generating a ranking of a differential impact on survival for each of the at least one gene in the two groups, and based on the generated ranking, identifying genes whose state is more important to survival in the group who do not benefit from the therapy or intervention.

Patent Agency Ranking